Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Seegene, Inc.
  6. Summary
    A096530   KR7096530001

SEEGENE, INC.

(A096530)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Korea Stock Exchange
07/19/2021 07/20/2021 07/21/2021 07/22/2021 07/23/2021 Date
77400 80100 78700 76200 76000 Last
2012656 2544337 1406556 1546826 873525 Volume
+0.26% +3.49% -1.75% -3.18% -0.26% Change
Estimated financial data (e)
Sales 2021 1 225 B 1,06 B 1,06 B
Net income 2021 480 B 0,42 B 0,42 B
Net cash position 2021 1 271 B 1,10 B 1,10 B
P/E ratio 2021 10,3x
Yield 2021 0,89%
Sales 2022 884 B 0,77 B 0,77 B
Net income 2022 357 B 0,31 B 0,31 B
Net cash position 2022 1 815 B 1,58 B 1,58 B
P/E ratio 2022 12,2x
Yield 2022 0,66%
Capitalization 3 932 B 3 407 M 3 417 M
EV / Sales 2021 2,17x
EV / Sales 2022 2,40x
Nbr of Employees 744
Free-Float 67,9%
More Financials
Company
Seegene Inc is a Korea-based company engaged in the development, manufacturing and distribution of molecular diagnostic reagents. The Company mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP)... 
More about the company
Ratings of Seegene, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about SEEGENE, INC.
07/13SEEGENE : Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six ..
AQ
07/13Seegene Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six..
CI
07/06SEEGENE : announces partnership with Bio-Rad to develop diagnostic testing produ..
AQ
06/29SEEGENE : unveils "MOBILE STATION," for on-site routine testing at public-use fa..
AQ
06/29Seegene Inc. Introduces its New Deployable Container Laboratory "Mobile Stati..
CI
05/25SEEGENE : reports solid results in the first quarter of 2021 with KRW 351.8 bill..
AQ
05/23SEEGENE : introduces an exclusive diagnostic system for diagnosing COVID-19 vari..
AQ
05/23Seegene, Inc. Introduces an Exclusive Diagnostic System for Diagnosing Covid-..
CI
05/18SEEGENE : signs exclusive supply agreement with the Kuwaiti government
AQ
05/11SEEGENE : reports solid results in the first quarter of 2021 with KRW 351.8 bill..
AQ
05/11Seegene Inc. Reports Earnings Results for the First Quarter of 2021
CI
05/10SEEGENE : Germany subsidiary supports the back-to-school initiative with its COV..
AQ
04/21SEEGENE : to supply COVID-19 diagnostic tests worth 16 mil. GBP to Scotland, tri..
AQ
04/21Seegene to Supply Covid-19 Diagnostic Tests Worth GBP 16 Million to Scotland
CI
04/15SEEGENE : Italy subsidiary secures public procurement for 7.15 million COVID-19 ..
AQ
More news
News in other languages on SEEGENE, INC.
02/12++ Analysen des Tages von Dow Jones Newswires (12.02.2021) +++
02/12SEEGENE : ANALYSE/Südkoreas Gewinnabschöpfungsidee als internationales Vorbild?
More news
Chart SEEGENE, INC.
Duration : Period :
Seegene, Inc. Technical Analysis Chart | A096530 | KR7096530001 | MarketScreener
Technical analysis trends SEEGENE, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 76 000,00 KRW
Average target price 116 750,00 KRW
Spread / Average Target 53,6%
EPS Revisions
Managers and Directors
Jong-Yoon Chun Chief Executive Officer & Director
Jung-Yong Kim Director & Head-Finance
Hong-Il Yoon Independent Director
Chang-Se Lee Independent Director
Kyung-Jun Chun Director
Sector and Competitors
1st jan.Capi. (M$)
SEEGENE, INC.-21.24%3 851
EXACT SCIENCES CORPORATION-10.97%22 056
GUARDANT HEALTH, INC.-7.64%12 461
BGI GENOMICS CO., LTD.-22.10%7 539
INVITAE CORPORATION-32.60%6 884
ADAPTIVE BIOTECHNOLOGIES CORPORATION-34.50%5 670